{"openapi":"3.0.0","servers":[{"url":"https://dev.burni.xn--7-c56d.com/"}],"info":{"title":"Burni API documentation","version":"v2.1.0","description":"Documentation for the REST API"},"paths":{"/fhir/MedicinalProductIndication":{"post":{"operationId":"createMedicinalProductIndication","tags":["MedicinalProductIndication"],"summary":"create MedicinalProductIndication resource.","parameters":[],"requestBody":{"content":{"application/fhir+json":{"schema":{"$ref":"#/components/schemas/createMedicinalProductIndication"},"examples":{"json-example":{"value":{"resourceType":"MedicinalProductIndication","id":"example","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>diseaseSymptomProcedure</b>: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). <span>(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)</span></p><p><b>comorbidity</b>: Hipsurgery <span>(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)</span></p><p><b>intendedEffect</b>: PRYLX <span>(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)</span></p><p><b>population</b>: </p></div>"},"diseaseSymptomProcedure":{"coding":[{"system":"http://ema.europa.eu/example/indicationasdisease-symptom-procedure","code":"Venousthromboembolismprophylaxis"}],"text":"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."},"comorbidity":[{"coding":[{"system":"http://ema.europa.eu/example/comorbidity","code":"Hipsurgery"}]}],"intendedEffect":{"coding":[{"system":"http://ema.europa.eu/example/intendedeffect","code":"PRYLX"}]},"population":[{"ageRange":{"low":{"value":18,"unit":"a"}}}],"meta":{"tag":[{"system":"http://terminology.hl7.org/CodeSystem/v3-ActReason","code":"HTEST","display":"test health data"}]}}}}},"application/fhir+xml":{"schema":{"$ref":"#/components/schemas/createMedicinalProductIndication","xml":{"name":"MedicinalProductIndication"}},"examples":{"xml-example":{"value":"\n<?xml version=\"1.0\" encoding=\"UTF-8\"?><MedicinalProductIndication xmlns=\"http://hl7.org/fhir\"><id value=\"example\"/><meta><tag><system value=\"http://terminology.hl7.org/CodeSystem/v3-ActReason\"/><code value=\"HTEST\"/><display value=\"test health data\"/></tag></meta><text><status value=\"generated\"/><div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>diseaseSymptomProcedure</b>: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). <span>(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)</span></p><p><b>comorbidity</b>: Hipsurgery <span>(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)</span></p><p><b>intendedEffect</b>: PRYLX <span>(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)</span></p><p><b>population</b>: </p></div></text><diseaseSymptomProcedure><coding><system value=\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\"/><code value=\"Venousthromboembolismprophylaxis\"/></coding><text value=\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"/></diseaseSymptomProcedure><comorbidity><coding><system value=\"http://ema.europa.eu/example/comorbidity\"/><code value=\"Hipsurgery\"/></coding></comorbidity><intendedEffect><coding><system value=\"http://ema.europa.eu/example/intendedeffect\"/><code value=\"PRYLX\"/></coding></intendedEffect><population><ageRange><low><value value=\"18\"/><unit value=\"a\"/></low></ageRange></population></MedicinalProductIndication>"}}}}},"description":"create MedicinalProductIndication resource.","responses":{"200":{"description":"successful operation","content":{"application/fhir+json":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"}},"examples":{"json-example":{"value":{"resourceType":"MedicinalProductIndication","id":"61904286-cdc0-4700-9c7a-d5f3d9bad827","diseaseSymptomProcedure":{"coding":[{"system":"http://ema.europa.eu/example/indicationasdisease-symptom-procedure","code":"Venousthromboembolismprophylaxis"}],"text":"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."},"comorbidity":[{"coding":[{"system":"http://ema.europa.eu/example/comorbidity","code":"Hipsurgery"}]}],"intendedEffect":{"coding":[{"system":"http://ema.europa.eu/example/intendedeffect","code":"PRYLX"}]},"population":[{"ageRange":{"low":{"value":18,"unit":"a"}}}],"meta":{"tag":[{"system":"http://terminology.hl7.org/CodeSystem/v3-ActReason","code":"HTEST","display":"test health data"}],"versionId":"1","lastUpdated":"2022-02-13T22:30:17.924+08:00"}}}}},"application/fhir+xml":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"},"xml":{"name":"MedicinalProductIndication"}},"examples":{"xml-example":{"value":"<?xml version=\"1.0\" encoding=\"UTF-8\"?><MedicinalProductIndication xmlns=\"http://hl7.org/fhir\"><id value=\"80efee93-8d5a-4f98-aba7-ed1a8e88e0fc\"/><meta><versionId value=\"1\"/><lastUpdated value=\"2022-02-17T17:34:54.818+08:00\"/><tag><system value=\"http://terminology.hl7.org/CodeSystem/v3-ActReason\"/><code value=\"HTEST\"/><display value=\"test health data\"/></tag></meta><diseaseSymptomProcedure><coding><system value=\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\"/><code value=\"Venousthromboembolismprophylaxis\"/></coding><text value=\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"/></diseaseSymptomProcedure><comorbidity><coding><system value=\"http://ema.europa.eu/example/comorbidity\"/><code value=\"Hipsurgery\"/></coding></comorbidity><intendedEffect><coding><system value=\"http://ema.europa.eu/example/intendedeffect\"/><code value=\"PRYLX\"/></coding></intendedEffect><population><ageRange><low><value value=\"18\"/><unit value=\"a\"/></low></ageRange></population></MedicinalProductIndication>"}}}}},"400":{"description":"error","content":{"application/fhir+json":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"}},"examples":{"Bad-Request-Response":{"value":{"resourceType":"OperationOutcome","issue":[{"severity":"error","code":"exception","diagnostics":"validation error, path `resourceType` is required"}]}}}},"application/fhir+xml":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"},"xml":{"name":"OperationOutcome"}},"examples":{"Bad-Request-Response":{"value":"\n<OperationOutcome xmlns='http://hl7.org/fhir'>\n<issue>\n    <severity value='error'/>\n    <code value='exception'/>\n    <diagnostics value='validation error, path `resourceType` is required'/>\n</issue>\n</OperationOutcome>"}}}}}},"x-codeSamples":[{"lang":"Shell","source":"#example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\ncurl --location --request POST 'http://burni.example.com/fhir/MedicinalProductIndication \\' \n--header 'Content-Type: application/fhir+json' \\\n--data-raw '{\"resourceType\":\"MedicinalProductIndication\",\"id\":\"61904286-cdc0-4700-9c7a-d5f3d9bad827\",\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":18,\"unit\":\"a\"}}}],\"meta\":{\"tag\":[{\"system\":\"http://terminology.hl7.org/CodeSystem/v3-ActReason\",\"code\":\"HTEST\",\"display\":\"test health data\"}],\"versionId\":\"1\",\"lastUpdated\":\"2022-02-13T22:30:17.924+08:00\"}}'","label":"cURL"},{"lang":"JavaScript","source":" //example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\nconst axios = require('axios');\nconst data = {\"resourceType\":\"MedicinalProductIndication\",\"id\":\"61904286-cdc0-4700-9c7a-d5f3d9bad827\",\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":18,\"unit\":\"a\"}}}],\"meta\":{\"tag\":[{\"system\":\"http://terminology.hl7.org/CodeSystem/v3-ActReason\",\"code\":\"HTEST\",\"display\":\"test health data\"}],\"versionId\":\"1\",\"lastUpdated\":\"2022-02-13T22:30:17.924+08:00\"}}\nconst config = {\n    method: 'post',\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication',\n    headers: { \n        'Content-Type': 'application/fhir+json'\n    },\n    data: data\n};\n\naxios(config)\n.then(function (response) {\n    console.log(JSON.stringify(response.data));\n})\n.catch(function (error) {\n    console.log(error);\n});","label":"javascript Axios"}]}},"/fhir/MedicinalProductIndication/{id}":{"delete":{"operationId":"deleteMedicinalProductIndication","tags":["MedicinalProductIndication"],"summary":"delete MedicinalProductIndication resource by id.","parameters":[{"name":"id","in":"path","required":true,"schema":{"type":"string"},"description":"Resource ID in server"}],"responses":{"200":{"description":"successful operation","content":{"application/fhir+json":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"}},"examples":{"Success-Response":{"value":{"resourceType":"OperationOutcome","issue":[{"severity":"information","code":"informational","diagnostics":"delete MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827 successfully"}]}}}},"application/fhir+xml":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"},"xml":{"name":"OperationOutcome"}},"examples":{"Success-Response-XML":{"value":"<OperationOutcome xmlns='http://hl7.org/fhir'>\n    <issue>\n    <severity value='information'/>\n    <code value='informational'/>\n    <diagnostics value='delete MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827 successfully'/>\n    </issue>\n</OperationOutcome>"}}}}},"404":{"description":"error","content":{"application/fhir+json":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"}},"examples":{"Not-Found-Response":{"value":{"resourceType":"OperationOutcome","issue":[{"severity":"error","code":"exception","diagnostics":"The id->61904286-cdc0-4700-9c7a-d5f3d9bad827 not found in MedicinalProductIndication resource"}]}}}},"application/fhir+xml":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"},"xml":{"name":"OperationOutcome"}},"examples":{"Not-Found-Response-XML":{"value":"<OperationOutcome xmlns='http://hl7.org/fhir'>\n    <issue>\n    <severity value='error'/>\n    <code value='not-found'/>\n    <diagnostics value='The id-&gt;61904286-cdc0-4700-9c7a-d5f3d9bad827  not found in MedicinalProductIndication resource'/>\n    </issue>\n</OperationOutcome>"}}}}}},"x-codeSamples":[{"lang":"Shell","source":"#example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\ncurl --location --request DELETE 'http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'","label":"cURL"},{"lang":"JavaScript","source":" //example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\nconst axios = require('axios');\nconst config = {\n    method: 'delete',\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'\n};\n\naxios(config)\n.then(function (response) {\n    console.log(JSON.stringify(response.data));\n})\n.catch(function (error) {\n    console.log(error);\n});","label":"javascript Axios"}]},"get":{"operationId":"readMedicinalProductIndication","tags":["MedicinalProductIndication"],"summary":"read MedicinalProductIndication resource by id.","parameters":[{"name":"id","in":"path","required":true,"schema":{"type":"string"},"description":"Resource ID in server"}],"responses":{"200":{"description":"successful operation","content":{"application/fhir+json":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"}},"examples":{"Success-Response":{"value":{"resourceType":"MedicinalProductIndication","id":"61904286-cdc0-4700-9c7a-d5f3d9bad827","diseaseSymptomProcedure":{"coding":[{"system":"http://ema.europa.eu/example/indicationasdisease-symptom-procedure","code":"Venousthromboembolismprophylaxis"}],"text":"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)."},"comorbidity":[{"coding":[{"system":"http://ema.europa.eu/example/comorbidity","code":"Hipsurgery"}]}],"intendedEffect":{"coding":[{"system":"http://ema.europa.eu/example/intendedeffect","code":"PRYLX"}]},"population":[{"ageRange":{"low":{"value":18,"unit":"a"}}}],"meta":{"tag":[{"system":"http://terminology.hl7.org/CodeSystem/v3-ActReason","code":"HTEST","display":"test health data"}],"versionId":"1","lastUpdated":"2022-02-13T22:30:17.924+08:00"}}}}},"application/fhir+xml":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"},"xml":{"name":"MedicinalProductIndication"}},"examples":{"Success-Response-XML":{"value":"<?xml version=\"1.0\" encoding=\"UTF-8\"?><MedicinalProductIndication xmlns=\"http://hl7.org/fhir\"><id value=\"80efee93-8d5a-4f98-aba7-ed1a8e88e0fc\"/><meta><versionId value=\"1\"/><lastUpdated value=\"2022-02-17T17:34:54.818+08:00\"/><tag><system value=\"http://terminology.hl7.org/CodeSystem/v3-ActReason\"/><code value=\"HTEST\"/><display value=\"test health data\"/></tag></meta><diseaseSymptomProcedure><coding><system value=\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\"/><code value=\"Venousthromboembolismprophylaxis\"/></coding><text value=\"Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients).\"/></diseaseSymptomProcedure><comorbidity><coding><system value=\"http://ema.europa.eu/example/comorbidity\"/><code value=\"Hipsurgery\"/></coding></comorbidity><intendedEffect><coding><system value=\"http://ema.europa.eu/example/intendedeffect\"/><code value=\"PRYLX\"/></coding></intendedEffect><population><ageRange><low><value value=\"18\"/><unit value=\"a\"/></low></ageRange></population></MedicinalProductIndication>"}}}}},"404":{"description":"error","content":{"application/fhir+json":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"}},"examples":{"Not-Found-Response":{"value":{"resourceType":"OperationOutcome","issue":[{"severity":"error","code":"exception","diagnostics":"not found MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827"}]}}}},"application/fhir+xml":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"},"xml":{"name":"OperationOutcome"}},"examples":{"Not-Found-Response-XML":{"value":"<OperationOutcome xmlns='http://hl7.org/fhir'>\n<issue>\n    <severity value='error'/>\n    <code value='exception'/>\n    <diagnostics value='not found MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'/>\n</issue>\n</OperationOutcome>"}}}}}},"x-codeSamples":[{"lang":"Shell","source":"#example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\ncurl --location --request GET 'http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'","label":"cURL"},{"lang":"JavaScript","source":" //example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\nconst axios = require('axios');\nconst config = {\n    method: 'get',\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication/61904286-cdc0-4700-9c7a-d5f3d9bad827'\n};\n\naxios(config)\n.then(function (response) {\n    console.log(JSON.stringify(response.data));\n})\n.catch(function (error) {\n    console.log(error);\n});","label":"javascript Axios"}]},"put":{"operationId":"updateMedicinalProductIndication","tags":["MedicinalProductIndication"],"summary":"update MedicinalProductIndication resource.","parameters":[{"name":"id","in":"path","required":true,"schema":{"type":"string"},"description":"Resource ID that you want to update"}],"requestBody":{"content":{"application/fhir+json":{"schema":{"$ref":"#/components/schemas/updateMedicinalProductIndication"},"examples":{"json-example":{"value":{"resourceType":"MedicinalProductIndication","id":"example","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>diseaseSymptomProcedure</b>: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). <span>(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)</span></p><p><b>comorbidity</b>: Hipsurgery <span>(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)</span></p><p><b>intendedEffect</b>: PRYLX <span>(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)</span></p><p><b>population</b>: </p></div>"},"diseaseSymptomProcedure":{"coding":[{"system":"http://ema.europa.eu/example/indicationasdisease-symptom-procedure","code":"Venousthromboembolismprophylaxis"}],"text":"pq7TgegGiaq"},"comorbidity":[{"coding":[{"system":"http://ema.europa.eu/example/comorbidity","code":"Hipsurgery"}]}],"intendedEffect":{"coding":[{"system":"http://ema.europa.eu/example/intendedeffect","code":"PRYLX"}]},"population":[{"ageRange":{"low":{"value":57693,"unit":"a"}}}],"meta":{"tag":[{"system":"http://terminology.hl7.org/CodeSystem/v3-ActReason","code":"HTEST","display":"IamoeA459qC2O"}]}}}}},"application/fhir+xml":{"schema":{"$ref":"#/components/schemas/updateMedicinalProductIndication","xml":{"name":"MedicinalProductIndication"}},"examples":{"xml-example":{"value":"\n<?xml version=\"1.0\" encoding=\"UTF-8\"?><MedicinalProductIndication xmlns=\"http://hl7.org/fhir\"><id value=\"example\"/><meta><tag><system value=\"http://terminology.hl7.org/CodeSystem/v3-ActReason\"/><code value=\"HTEST\"/><display value=\"IamoeA459qC2O\"/></tag></meta><text><status value=\"generated\"/><div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>diseaseSymptomProcedure</b>: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). <span>(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)</span></p><p><b>comorbidity</b>: Hipsurgery <span>(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)</span></p><p><b>intendedEffect</b>: PRYLX <span>(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)</span></p><p><b>population</b>: </p></div></text><diseaseSymptomProcedure><coding><system value=\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\"/><code value=\"Venousthromboembolismprophylaxis\"/></coding><text value=\"pq7TgegGiaq\"/></diseaseSymptomProcedure><comorbidity><coding><system value=\"http://ema.europa.eu/example/comorbidity\"/><code value=\"Hipsurgery\"/></coding></comorbidity><intendedEffect><coding><system value=\"http://ema.europa.eu/example/intendedeffect\"/><code value=\"PRYLX\"/></coding></intendedEffect><population><ageRange><low><value value=\"57693\"/><unit value=\"a\"/></low></ageRange></population></MedicinalProductIndication>"}}}}},"description":"update MedicinalProductIndication resource.","responses":{"200":{"description":"successful operation","content":{"application/fhir+json":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"}},"examples":{"json-example":{"value":{"resourceType":"MedicinalProductIndication","id":"MedicinalProductIndication-example","diseaseSymptomProcedure":{"coding":[{"system":"http://ema.europa.eu/example/indicationasdisease-symptom-procedure","code":"Venousthromboembolismprophylaxis"}],"text":"pq7TgegGiaq"},"comorbidity":[{"coding":[{"system":"http://ema.europa.eu/example/comorbidity","code":"Hipsurgery"}]}],"intendedEffect":{"coding":[{"system":"http://ema.europa.eu/example/intendedeffect","code":"PRYLX"}]},"population":[{"ageRange":{"low":{"value":57693,"unit":"a"}}}],"meta":{"versionId":"20","lastUpdated":"2022-02-17T23:28:25.651+08:00"}}}}},"application/fhir+xml":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"},"xml":{"name":"MedicinalProductIndication"}},"examples":{"xml-example":{"value":"<?xml version=\"1.0\" encoding=\"UTF-8\"?><MedicinalProductIndication xmlns=\"http://hl7.org/fhir\"><id value=\"MedicinalProductIndication-example\"/><meta><versionId value=\"22\"/><lastUpdated value=\"2022-02-18T00:39:38.858+08:00\"/></meta><diseaseSymptomProcedure><coding><system value=\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\"/><code value=\"Venousthromboembolismprophylaxis\"/></coding><text value=\"pq7TgegGiaq\"/></diseaseSymptomProcedure><comorbidity><coding><system value=\"http://ema.europa.eu/example/comorbidity\"/><code value=\"Hipsurgery\"/></coding></comorbidity><intendedEffect><coding><system value=\"http://ema.europa.eu/example/intendedeffect\"/><code value=\"PRYLX\"/></coding></intendedEffect><population><ageRange><low><value value=\"57693\"/><unit value=\"a\"/></low></ageRange></population></MedicinalProductIndication>"}}}}},"400":{"description":"error","content":{"application/fhir+json":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"}},"examples":{"Bad-Request-Response":{"value":{"resourceType":"OperationOutcome","issue":[{"severity":"error","code":"exception","diagnostics":"validation error, path `resourceType` is required"}]}}}},"application/fhir+xml":{"schema":{"type":"object","items":{"$ref":"#/components/schemas/FHIR-XML-RESOURCE"},"xml":{"name":"OperationOutcome"}},"examples":{"Bad-Request-Response":{"value":"\n<OperationOutcome xmlns='http://hl7.org/fhir'>\n<issue>\n    <severity value='error'/>\n    <code value='exception'/>\n    <diagnostics value='validation error, path `resourceType` is required'/>\n</issue>\n</OperationOutcome>"}}}}}},"x-codeSamples":[{"lang":"Shell","source":"#example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\ncurl --location --request PUT 'http://burni.example.com/fhir/MedicinalProductIndication/MedicinalProductIndication-example \\' \n--header 'Content-Type: application/fhir+json' \\\n--data-raw '{\"resourceType\":\"MedicinalProductIndication\",\"id\":\"example\",\"text\":{\"status\":\"generated\",\"div\":\"<div xmlns=\\\"http://www.w3.org/1999/xhtml\\\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>diseaseSymptomProcedure</b>: Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\\\nor knee replacement surgery.\\\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients). <span>(Details : {http://ema.europa.eu/example/indicationasdisease-symptom-procedure code 'Venousthromboembolismprophylaxis' = 'Venousthromboembolismprophylaxis)</span></p><p><b>comorbidity</b>: Hipsurgery <span>(Details : {http://ema.europa.eu/example/comorbidity code 'Hipsurgery' = 'Hipsurgery)</span></p><p><b>intendedEffect</b>: PRYLX <span>(Details : {http://ema.europa.eu/example/intendedeffect code 'PRYLX' = 'PRYLX)</span></p><p><b>population</b>: </p></div>\"},\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"pq7TgegGiaq\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":57693,\"unit\":\"a\"}}}],\"meta\":{\"tag\":[{\"system\":\"http://terminology.hl7.org/CodeSystem/v3-ActReason\",\"code\":\"HTEST\",\"display\":\"IamoeA459qC2O\"}]}}'","label":"cURL"},{"lang":"JavaScript","source":" //example from: https://chinlinlee.github.io/Burni/assets/FHIR/fhir-resource-examples/medicinalproductindication-example.json\nconst axios = require('axios');\nconst data = {\"resourceType\":\"MedicinalProductIndication\",\"id\":\"MedicinalProductIndication-example\",\"diseaseSymptomProcedure\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/indicationasdisease-symptom-procedure\",\"code\":\"Venousthromboembolismprophylaxis\"}],\"text\":\"pq7TgegGiaq\"},\"comorbidity\":[{\"coding\":[{\"system\":\"http://ema.europa.eu/example/comorbidity\",\"code\":\"Hipsurgery\"}]}],\"intendedEffect\":{\"coding\":[{\"system\":\"http://ema.europa.eu/example/intendedeffect\",\"code\":\"PRYLX\"}]},\"population\":[{\"ageRange\":{\"low\":{\"value\":57693,\"unit\":\"a\"}}}],\"meta\":{\"versionId\":\"20\",\"lastUpdated\":\"2022-02-17T23:28:25.651+08:00\"}}\nconst config = {\n    method: 'put',\n    url: 'http://burni.example.com/fhir/MedicinalProductIndication/MedicinalProductIndication-example',\n    headers: { \n        'Content-Type': 'application/fhir+json'\n    },\n    data: data\n};\n\naxios(config)\n.then(function (response) {\n    console.log(JSON.stringify(response.data));\n})\n.catch(function (error) {\n    console.log(error);\n});","label":"javascript Axios"}]}}},"components":{"schemas":{"createMedicinalProductIndication":{"properties":{"resourceType":{"type":"string","description":""}},"required":["resourceType"]},"FHIR-JSON-RESOURCE":{"properties":{}},"FHIR-XML-RESOURCE":{"properties":{}},"deleteMedicinalProductIndication":{"properties":{"id":{"type":"string","description":"Resource ID in server"}},"required":["id"]},"readMedicinalProductIndication":{"properties":{"id":{"type":"string","description":"Resource ID in server"}},"required":["id"]},"updateMedicinalProductIndication":{"properties":{"id":{"type":"string","description":"Resource ID that you want to update"},"resourceType":{"type":"string","description":""}},"required":["id","resourceType"]}}}}